RNA processing in skeletal muscle biology and disease

References

• Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int. 2015;96:183–195.
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, Wang Z, et al. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol. 2000;89:81–88.
   PubMed Web of Science ®Google Scholar
• Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol Rev. 2011;91:1447–1531.
   PubMed Web of Science ®Google Scholar
• Zierath JR, Hawley JA. Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol. 2004;2:e348.
   PubMed Web of Science ®Google Scholar
• Trovato F, Imbesi R, Conway N, et al. Morphological and functional aspects of human skeletal muscle. J Funct Morphol Kinesiol. 2016;1:289–302.
   Google Scholar
• Takekura H, Flucher BE, Franzini-Armstrong C. Sequential docking, molecular differentiation, and positioning of T-tubule/SR junctions in developing mouse skeletal muscle. Dev Biol. 2001;239:204–214.
   PubMed Web of Science ®Google Scholar
• Franzini-Armstrong C. Simultaneous maturation of transverse tubules and sarcoplasmic reticulum during muscle differentiation in the mouse. Dev Biol. 1991;146:353–363.
   PubMed Web of Science ®Google Scholar
• Greising SM, Gransee HM, Mantilla CB, et al. Systems biology of skeletal muscle: fiber type as an organizing principle. Wiley Interdiscip Rev Syst Biol Med. 2012;4:457–473.
   PubMed Web of Science ®Google Scholar
• Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem. 2006;75:19–37.
   PubMed Web of Science ®Google Scholar
• Black AJ, Ravi S, Jefferson LS, et al. Dietary fat quantity and type induce transcriptome-wide effects on alternative splicing of pre-mRNA in rat skeletal muscle. J Nutr. 2017;147:jn254482.
   Web of Science ®Google Scholar
• Clarke K, Ricciardi S, Pearson T, et al. The role of Eif6 in skeletal muscle homeostasis revealed by endurance training co-expression networks. Cell Rep. 2017;21:1507–1520.
   PubMed Web of Science ®Google Scholar
• Phillips SM, Glover EI, Rennie MJ. Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. J Appl Physiol. 2009;107:645–654.
   PubMed Web of Science ®Google Scholar
• Sylow L, Kleinert M, Richter EA, et al. Exercise-stimulated glucose uptake — regulation and implications for glycaemic control. Nat Rev Endocrinol. 2017;13:133–148.
   PubMed Web of Science ®Google Scholar
• Lenasi T, Peterlin BM, Barboric M. Cap-binding protein complex links pre-mRNA capping to transcription elongation and alternative splicing through positive transcription elongation factor b (P-TEFb). J Biol Chem. 2011;286:22758–22768.
   PubMed Web of Science ®Google Scholar
• Ramanathan A, Robb GB, Chan SH. mRNA capping: biological functions and applications. Nucleic Acids Res. 2016;44:7511–7526.
   PubMed Web of Science ®Google Scholar
• Moteki S, Price D. Functional coupling of capping and transcription of mRNA. Mol Cell. 2002;10:599–609.
   PubMed Web of Science ®Google Scholar
• Shatkin AJ, Manley JL. The ends of the affair: capping and polyadenylation. Nat Struct Biol. 2000;7:838–842.
   PubMedGoogle Scholar
• Gonatopoulos-Pournatzis T, Cowling VH. Cap-binding complex (CBC). Biochem J. 2014;457:231–242.
   PubMed Web of Science ®Google Scholar
• Pabis M, Neufeld N, Steiner MC, et al. The nuclear cap-binding complex interacts with the U4/U6·U5 tri-snRNP and promotes spliceosome assembly in mammalian cells. Rna. 2013;19:1054–1063.
   PubMed Web of Science ®Google Scholar
• Flaherty SM, Fortes P, Izaurralde E, et al. Participation of the nuclear cap binding complex in pre-mRNA 3ʹ processing. Proc Natl Acad Sci USA. 1997;94:11893–11898.
   PubMed Web of Science ®Google Scholar
• Andersen PR, Domanski M, Kristiansen MS, et al. The human cap-binding complex is functionally connected to the nuclear RNA exosome. Nat Struct Mol Biol. 2013;20:1367–1376.
   PubMed Web of Science ®Google Scholar
• Izaurralde E, Adam S. Transport of macromolecules between the nucleus and the cytoplasm. Rna. 1998;4:351–364.
   PubMed Web of Science ®Google Scholar
• Nojima T, Hirose T, Kimura H, et al. The interaction between cap-binding complex and RNA export factor is required for intronless mRNA export. J Biol Chem. 2007;282:15645–15651.
   PubMed Web of Science ®Google Scholar
• Daneholt B. Assembly and transport of a premessenger RNP particle. Proc Natl Acad Sci USA. 2001;98:7012–7017.
   PubMed Web of Science ®Google Scholar
• Grüner S, Peter D, Weber R, et al. The structures of eIF4E-eIF4G complexes reveal an extended interface to regulate translation initiation. Mol Cell. 2016;64:467–479.
   PubMed Web of Science ®Google Scholar
• Jackson RJ, Hellen CUT, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol. 2010;11:113–127.
   PubMed Web of Science ®Google Scholar
• Pestova TV, Kolupaeva VG, Lomakin IB, et al. Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci USA. 2001;98:7029–7036.
   PubMed Web of Science ®Google Scholar
• Frey JW, Jacobs BL, Goodman CA, et al. A role for Raptor phosphorylation in the mechanical activation of mTOR signaling. Cell Signal. 2014;26:313–322.
   PubMed Web of Science ®Google Scholar
• Gordon BS, Williamson DL, Lang CH, et al. Nutrient-induced stimulation of protein synthesis in mouse skeletal muscle is limited by the mTORC1 repressor REDD1. J Nutr. 2015;145:708–713.
   PubMed Web of Science ®Google Scholar
• Gordon BS, Steiner JL, Lang CH, et al. Reduced REDD1 expression contributes to activation of mTORC1 following electrically induced muscle contraction. Am J Physiol Endocrinol Metab. 2014;307:E703–11.
   PubMed Web of Science ®Google Scholar
• Rossetti ML, Fukuda DH, Gordon BS. Androgens induce growth of the limb skeletal muscles in a rapamycin-insensitive manner. Am J Physiol Integr Comp Physiol. 2018; 315:R721-R729.
   PubMed Web of Science ®Google Scholar
• Kelleher AR, Kimball SR, Dennis MD, et al. The mTORC1 signaling repressors REDD1/2 are rapidly induced and activation of p70S6K1 by leucine is defective in skeletal muscle of an immobilized rat hindlimb. AJP Endocrinol Metab. 2013;304:E229–36.
   PubMed Web of Science ®Google Scholar
• Kelleher AR, Gordon BS, Kimball SR, et al. Changes in REDD1, REDD2, and atrogene mRNA expression are prevented in skeletal muscle fixed in a stretched position during hindlimb immobilization. Physiol Rep. 2014;2:246.
   Google Scholar
• Kelleher AR, Pereira SL, Jefferson LS, et al. REDD2 expression in rat skeletal muscle correlates with nutrient-induced activation of mTORC1: responses to aging, immobilization, and remobilization. Am J Physiol Endocrinol Metab. 2015;308:122–129.
   Web of Science ®Google Scholar
• Gingras AC, Kennedy SG, O’Leary MA, et al. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 1998;12:502–513.
   PubMed Web of Science ®Google Scholar
• Haghighat A, Mader S, Pause A, et al. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. Embo J. 1995;14:5701–5709.
   PubMed Web of Science ®Google Scholar
• Suzuki C, Garces RG, Edmonds KA, et al. PDCD4 inhibits translation initiation by binding to eIF4A using both its MA3 domains. Proc Natl Acad Sci U S A. 2008;105:3274–3279.
   PubMed Web of Science ®Google Scholar
• Dennis MD, Shenberger JS, Stanley BA, et al. Hyperglycemia mediates a shift from cap-dependent to cap-independent translation via a 4E-BP1-dependent mechanism. Diabetes. 2013;62:2204–2214.
   PubMed Web of Science ®Google Scholar
• Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001;3:1009–1013.
   PubMed Web of Science ®Google Scholar
• Binsch C, Jelenik T, Pfitzer A, et al. Absence of the kinase S6k1 mimics the effect of chronic endurance exercise on glucose tolerance and muscle oxidative stress. Mol Metab. 2017;6:1443–1453.
   PubMed Web of Science ®Google Scholar
• Ohanna M, Sobering AK, Lapointe T, et al. Atrophy of S6K1 −/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol. 2005;7:286–294.
   PubMed Web of Science ®Google Scholar
• Marabita M, Baraldo M, Solagna F, et al. S6K1 is required for increasing skeletal muscle force during hypertrophy. Cell Rep. 2016;17:501–513.
   PubMed Web of Science ®Google Scholar
• Steiner JL, Pruznak AM, Deiter G, et al. Disruption of genes encoding eIF4E binding proteins-1 and −2 does not alter basal or sepsis-induced changes in skeletal muscle protein synthesis in male or female mice. PLoS One. 2014;9:99582.
   Web of Science ®Google Scholar
• Merkin J, Russell C, Chen P, et al. Evolutionary dynamics of gene and isoform regulation in mammalian tissues. Science. 2012;338(6114):1593–1599.
   PubMed Web of Science ®Google Scholar
• Apponi LH, Corbett AH, Pavlath GK. RNA-binding proteins and gene regulation in myogenesis. Trends Pharmacol Sci. 2011;32:652–658.
   PubMed Web of Science ®Google Scholar
• Bland CS, Wang ET, Vu A, et al. Global regulation of alternative splicing during myogenic differentiation. Nucleic Acids Res. 2010;38:7651–7664.
   PubMed Web of Science ®Google Scholar
• Brinegar AE, Xia Z, Loehr JA, et al. Extensive alternative splicing transitions during postnatal skeletal muscle development are required for Ca 2+ handling. Elife. 2017;6:e27192.
   PubMed Web of Science ®Google Scholar
• Prokic I, Cowling BS, Laporte J. Amphiphysin 2 (BIN1) in physiology and diseases. J Mol Med. 2014;92:453–463.
   PubMed Web of Science ®Google Scholar
• Fugier C, Klein AF, Hammer C, et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med. 2011;17:720–725.
   PubMed Web of Science ®Google Scholar
• Tjondrokoesoemo A, Park KH, Ferrante C, et al. Disrupted membrane structure and intracellular Ca 2+ signaling in adult skeletal muscle with acute knockdown of Bin1. PLoS One. 2011;6.
   PubMed Web of Science ®Google Scholar
• Lee E, Marcucci M, Daniell L, et al. Amphiphysin 2 (Bin1) and T-tubule biogenesis in muscle. Science. 2002;297:1193–1196.
   PubMed Web of Science ®Google Scholar
• Pineda-Lucena A, Ho CSW, Mao DYL, et al. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants. J Mol Biol. 2005;351:182–194.
   PubMed Web of Science ®Google Scholar
• Ribeiro I, Yuan L, Tanentzapf G, et al. Phosphoinositide regulation of integrin trafficking required for muscle attachment and maintenance. PLoS Genet. 2011;7:e1001295.
   Web of Science ®Google Scholar
• Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443:651–657.
   PubMed Web of Science ®Google Scholar
• Böhm J, Vasli N, Maurer M, et al. Altered splicing of the BIN1 muscle-specific exon in humans and dogs with highly progressive centronuclear myopathy. PLoS Genet. 2013;9:e1003430.
   PubMed Web of Science ®Google Scholar
• Tuluc P, Molenda N, Schlick B, et al. A Cav1.1 Ca2+ channel splice variant with high conductance and voltage-sensitivity alters EC coupling in developing skeletal muscle. Biophys J. 2009;96:35–44.
   PubMed Web of Science ®Google Scholar
• Sultana N, Dienes B, Benedetti A, et al. Restricting calcium currents is required for correct fiber type specification in skeletal muscle. Development. 2016;143:1547–1559.
   PubMed Web of Science ®Google Scholar
• Tang ZZ, Yarotskyy V, Wei L, et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Cav1.1 calcium channel. Hum Mol Genet. 2012;21:1312–1324.
   PubMed Web of Science ®Google Scholar
• Santoro M, Masciullo M, Bonvissuto D, et al. Alternative splicing of human insulin receptor gene (INSR) in type i and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2. Mol Cell Biochem. 2013;380:259–265.
   PubMed Web of Science ®Google Scholar
• Mosthaf L, Grako K, Dull TJ, et al. Functionally distinct insulin receptors generated by tissue-specific alternative splicing. Embo J. 1990;9:2409–2413.
   PubMed Web of Science ®Google Scholar
• Seino S, Bell G. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun. 1989;159:312–316.
   PubMed Web of Science ®Google Scholar
• Belfiore A, Frasca F, Pandini G, et al. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev. 2009;30:586–623.
   PubMed Web of Science ®Google Scholar
• Talukdar I, Sen S, Urbano R, et al. HnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene. PLoS One. 2011;6.
   PubMed Web of Science ®Google Scholar
• Echeverria GV, Cooper TA. Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron. Nucleic Acids Res. 2014;42:1893–1903.
   PubMed Web of Science ®Google Scholar
• Sen S, Talukdar I, Webster NJG. SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing. Mol Cell Biol. 2009;29:871–880.
   PubMed Web of Science ®Google Scholar
• Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3:1014–1019.
   PubMed Web of Science ®Google Scholar
• Savkur RS, Philips AV, Cooper TA, et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet. 2004;74:1309–1313.
   PubMed Web of Science ®Google Scholar
• Michel RN, Dunn SE, Chin ER. Calcineurin and skeletal muscle growth. Proc Nutr Soc. 2004;63:341–349.
   PubMed Web of Science ®Google Scholar
• Kimura T, Pace SM, Wei L, et al. A variably spliced region in the type 1 ryanodine receptor may participate in an inter-domain interaction. Biochem J. 2007;401:317–324.
   PubMed Web of Science ®Google Scholar
• Delling U, Tureckova J, Lim HW, et al. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol. 2000;20:6600–6611.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cseresnyés Z, Randall WR, et al. Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers. J Cell Biol. 2001;155:27–39.
   PubMed Web of Science ®Google Scholar
• Chin ER, Olson EN, Richardson JA, et al. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 1998;12:2499–2509.
   PubMed Web of Science ®Google Scholar
• Giudice J, Loehr JA, Rodney GG, et al. Alternative splicing of four trafficking genes regulates myofiber structure and skeletal muscle physiology. Cell Rep. 2016;17:1923–1933.
   PubMed Web of Science ®Google Scholar
• Lee KM, Tarn WY. Coupling pre-mRNA processing to transcription on the RNA factory assembly line. RNA Biol. 2013;10:380–390.
   PubMed Web of Science ®Google Scholar
• Tian B, Manley JL. Alternative polyadenylation of mRNA precursors. Nat Rev Mol Cell Biol. 2016;18:18–30.
   PubMed Web of Science ®Google Scholar
• Chen W, Jia Q, Song Y, et al. Alternative polyadenylation: methods, findings, and impacts. Genomics Proteomics Bioinformatics. 2017;15:287–300.
   PubMed Web of Science ®Google Scholar
• Blazie SM, Babb C, Wilky H, et al. Comparative RNA-Seq analysis reveals pervasive tissue-specific alternative polyadenylation in Caenorhabditis elegans intestine and muscles. BMC Biol. 2015;13:4. DOI:10.1186/s12915-015-0116-6.
   Web of Science ®Google Scholar
• Boutet SC, Cheung TH, Quach NL, et al. Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. Cell Stem Cell. 2012;10:327–336.
   PubMed Web of Science ®Google Scholar
• Hirai H, Verma M, Watanabe S, et al. MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. J Cell Biol. 2010;10:327–336.
   Google Scholar
• Crist CG, Montarras D, Pallafacchina G, et al. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc Natl Acad Sci U S A. 2009;11:13383–13387.
   Google Scholar
• Fredericks AM, Cygan KJ, Brown BA, et al. RNA-binding proteins: splicing factors and disease. Biomolecules. 2015;5:893–909.
   PubMed Web of Science ®Google Scholar
• Hasan A, Cotobal C, Duncan CDS, et al. Systematic analysis of the role of RNA-binding proteins in the regulation of RNA stability. PLoS Genet. 2014;10:e1004684.
   PubMed Web of Science ®Google Scholar
• Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15:829–845.
   PubMed Web of Science ®Google Scholar
• Batra R, Charizanis K, Manchanda M, et al. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol Cell. 2014;56:311–322.
   PubMed Web of Science ®Google Scholar
• Martinez-Contreras R, Cloutier P, Shkreta L, et al. Alternative splicing in the postgenomic era. New York (NY): Springer Verlag New York; 2007.
   Google Scholar
• Martinez-Contreras R, Fisette JF, Nasim FUH, et al. Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol. 2006;4:172–185.
   Web of Science ®Google Scholar
• Sun S, Zhang ZUO, Fregoso O, et al. Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2. Rna. 2012;18:274–283.
   PubMed Web of Science ®Google Scholar
• Paul S, Dansithong W, Kim D, et al. Interaction of musleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. Embo J. 2006;25:4271–4283.
   PubMed Web of Science ®Google Scholar
• Li Q, Zheng S, Han A, et al. The splicing regulator PTBP2 controls a program of embryonic splicing required for neuronal maturation. Elife. 2014;3:e01201.
   PubMed Web of Science ®Google Scholar
• Wagner EJ, Garcia-Blanco MA. RNAi-mediated PTB depletion leads to enhanced exon definition. Mol Cell. 2002;10:943–949.
   PubMed Web of Science ®Google Scholar
• Xue Y, Zhou Y, Wu T, et al. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol Cell. 2009;36:996–1006.
   PubMed Web of Science ®Google Scholar
• Llorian M, Schwartz S, Clark TA, et al. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat Struct Mol Biol. 2010;17:1114–1123.
   PubMed Web of Science ®Google Scholar
• Keppetipola N, Sharma S, Li Q, et al. Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2. Crit Rev Biochem Mol Biol. 2012;47:360–378.
   PubMed Web of Science ®Google Scholar
• Tang ZZ, Sharma S, Zheng S, et al. Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein. J Biol Chem. 2011;286:10007–10016.
   PubMed Web of Science ®Google Scholar
• Hall MP, Nagel RJ, Fagg WS, et al. Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. Rna. 2013;19:627–638.
   PubMed Web of Science ®Google Scholar
• Galarneau A, Richard S. Target RNA motif and target mRNAs of the quaking STAR protein. Nat Struct Mol Biol. 2005;12:691–698.
   PubMed Web of Science ®Google Scholar
• Dasgupta T, Ladd A. The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA binding proteins. Wiley Interdiscip Rev RNA. 2012;3:104–121.
   PubMed Web of Science ®Google Scholar
• Vlasova IA, Tahoe NM, Fan D, et al. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. Mol Cell. 2008;29:263–270.
   PubMed Web of Science ®Google Scholar
• Kress C, Gautier-Courteille C, Osborne HB, et al. Inactivation of CUG-BP1/CELF1 causes growth, viability, and spermatogenesis defects in mice. Mol Cell Biol. 2007;27:1146–1157.
   PubMed Web of Science ®Google Scholar
• Giudice J, Xia Z, Li W, et al. Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1. Sci Rep. 2016;6:35550.
   PubMed Web of Science ®Google Scholar
• Wang ET, Ward AJ, Cherone JM, et al. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins. Genome Res. 2015;25:858–871.
   PubMed Web of Science ®Google Scholar
• Wang ET, Cody NAL, Jog S, et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell. 2012;150:710–724.
   PubMed Web of Science ®Google Scholar
• Kühn U, Gündel M, Knoth A, et al. Poly(A) tail length is controlled by the nuclear Poly(A)-binding protein regulating the interaction between Poly(A) polymerase and the cleavage and polyadenylation specificity factor. J Biol Chem. 2009;284:22803–22814.
   PubMed Web of Science ®Google Scholar
• Jenal M, Elkon R, Loayza-Puch F, et al. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell. 2012;149:538–553.
   PubMed Web of Science ®Google Scholar
• Abbassi-Daloii T, Yousefi S, de Klerk E, et al. An alanine expanded PABPN1 causes increased utilization of intronic polyadenylation sites. Aging Mech Dis. 2017;3:6.
   Google Scholar
• Goers ES, Purcell J, Voelker RB, et al. MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res. 2010;38:2467–2484.
   PubMed Web of Science ®Google Scholar
• Kanadia RN, Johnstone KA, Mankodi A, et al. A muscleblind knockout model for myotonic dystrophy. Science. 2003;302:1978–1980.
   PubMed Web of Science ®Google Scholar
• Suenaga K, Lee KY, Nakamori M, et al. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. PLoS One. 2012;7:e33218.
   PubMed Web of Science ®Google Scholar
• Singh RK, Kolonin AM, Fiorotto ML, et al. Rbfox-splicing factors maintain skeletal muscle mass by regulating calpain3 and proteostasis. Cell Rep. 2018;24:197–208.
   PubMed Web of Science ®Google Scholar
• Pedrotti S, Giudice J, Dagnino-Acosta A, et al. The RNA-binding protein Rbfox1 regulates splicing required for skeletal muscle structure and function. Hum Mol Genet. 2015;24:2360–2374.
   PubMed Web of Science ®Google Scholar
• Singh RK, Xia Z, Bland CS, et al. Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis. Mol Cell. 2014;55:592–603.
   PubMed Web of Science ®Google Scholar
• Lovci MT, Ghanem D, Marr H, et al. Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges. Nat Struct Mol Biol. 2013;20:1434–1442.
   PubMed Web of Science ®Google Scholar
• Sellier C, Cerro-Herreros E, Blatter M, et al. RbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences. Nat Commun. 2018;9:1–15.
   PubMed Web of Science ®Google Scholar
• Runfola V, Sebastian S, Dilworth FJ, et al. Rbfox proteins regulate tissue-specific alternative splicing of Mef2D required for muscle differentiation. J Cell Sci. 2015;128:631–637.
   PubMed Web of Science ®Google Scholar
• Penn BH, Bergstrom DA, Dilworth FJ, et al. A MyoD -generated feed-forward circuit temporally patterns gene expression dining skeletal muscle differentiation. Genes Dev. 2004;18:2348–2353.
   PubMed Web of Science ®Google Scholar
• Mal A, Sturniolo M, Schiltz RL, et al. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. Embo J. 2001;20:1739–1753.
   PubMed Web of Science ®Google Scholar
• Mal A, Harter ML. MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc Natl Acad Sci USA. 2003;100:1735–1739.
   PubMed Web of Science ®Google Scholar
• Puri PL, Sartorelli V, Yang XJ, et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell. 1997;1:35–45.
   PubMed Web of Science ®Google Scholar
• Asp P, Blum R, Vethantham V, et al. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci USA. 2011;108:E149–E158.
   PubMed Web of Science ®Google Scholar
• Gómez-Del Arco P, Perdiguero E, Yunes-Leites PS, et al. The chromatin remodeling complex Chd4/NuRD controls striated muscle identity and metabolic homeostasis. Cell Metab. 2016;23:881–892.
   PubMed Web of Science ®Google Scholar
• Schor IE, Rascovan N, Pelisch F, et al. Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing. Proc Natl Acad Sci USA. 2009;106:43225–43230.
   Web of Science ®Google Scholar
• Schor IE, Fiszbein A, Petrillo E, et al. Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation. Embo J. 2013;32:2264–2274.
   PubMed Web of Science ®Google Scholar
• Sims RJ, Millhouse S, Chen CF, et al. Recognition of trimethylated histone H3 Lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol Cell. 2007;28:665–676.
   PubMed Web of Science ®Google Scholar
• Saint-André V, Batsché E, Rachez C, et al. Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons. Nat Struct Mol Biol. 2011;18:337–344.
   PubMed Web of Science ®Google Scholar
• Luco RF, Pan Q, Tominaga K, et al. Regulation of alternative splicing by histone modifications. Science. 2010;327:996–1000.
   PubMed Web of Science ®Google Scholar
• Yong-Eun K, Chungoo P, Kyoon Eon K, et al. Histone and RNA-binding protein interaction creates crosstalk network for regulation of alternative splicing. Biochem Biophys Res Commun. 2018;499:30–36.
   PubMed Web of Science ®Google Scholar
• Jiang H, Mankodi A, Swanson MS, et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet. 2004;13:3079–3088.
   PubMed Web of Science ®Google Scholar
• Jauvin D, Chrétien J, Pandey SK, et al. Targeting DMPK with antisense oligonucleotide improves muscle strength in myotonic dystrophy type 1 mice. Mol Ther Nucleic Acids. 2017;7:465–474.
   PubMedGoogle Scholar
• Nakamori M, Sobczak K, Puwanant A, et al. Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol. 2014;74:862–872.
   Web of Science ®Google Scholar
• Thomas JD, Sznajder ŁJ, Bardhi O, et al. Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy. Genes Dev. 2017;31:1122–1133.
   PubMed Web of Science ®Google Scholar
• Fu YH, Pizzuti A, Fenwick RG Jr., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science. 1992;255:1256–1258.
   PubMed Web of Science ®Google Scholar
• Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3 ′ untranslated region of the gene. Science. 1992;255:1253–1255.
   PubMed Web of Science ®Google Scholar
• Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron I of ZNF9. Science. 2001;293:864–867.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Compton SA, Sobczak K, et al. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 2007;35:5474–5486.
   PubMed Web of Science ®Google Scholar
• Thomas JD, Oliveira R, Sznajder ŁJ, et al. Myotonic dystrophy and developmental regulation of RNA processing. Compr Physiol. 2018;8:509–553.
   PubMed Web of Science ®Google Scholar
• Savkur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet. 2001;29:40–47.
   PubMed Web of Science ®Google Scholar
• Kuyumcu-Martinez NM, Wang G-S, Cooper T. Increased steady state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyper-phosphorylation. Mol Cell. 2007;28:68–78.
   PubMed Web of Science ®Google Scholar
• Wheeler TM, Leger AJ, Pandey SK, et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature. 2014;488:111–115.
   Web of Science ®Google Scholar
• Scotti MM, Swanson MS. RNA mis-splicing in disease. Nat Rev Genet. 2016;17:19–32.
   PubMed Web of Science ®Google Scholar
• Nakamori M, Hamanaka K, Thomas JD, et al. Aberrant myokine signaling in congenital myotonic dystrophy. Cell Rep. 2017;21:1240–1252.
   PubMed Web of Science ®Google Scholar
• Pelosi M, De Rossi M, Barberi L, et al. IL-6 impairs myogenic differentiation by downmodulation of p90RSK/eEF2 and mTOR/p70S6K axes, without affecting AKT activity. Biomed Res Int. 2014;2014:206026.
   PubMed Web of Science ®Google Scholar
• Tuffery-Giraud S, Miro J, Koenig M, et al. Normal and altered pre-mRNA processing in the DMD gene. Hum Genet. 2017;136:1155–1172.
   PubMed Web of Science ®Google Scholar
• Lim KRQ, Maruyama R, Yokota T. Eteplirsen in the treatment of Duchenne muscular dystrophy. Drug Des Devel Ther. 2017;11:533–545.
   PubMed Web of Science ®Google Scholar
• Echigoya Y, Lim KRQ, Trieu N, et al. Quantitative antisense screening and optimization for exon 51 skipping in duchenne muscular dystrophy. Mol Ther. 2017;25:2561–2572.
   PubMed Web of Science ®Google Scholar
• Echevarría L, Aupy P, Goyenvalle A. Exon-skipping advances for Duchenne muscular dystrophy. Hum Mol Genet. 2018;27:163–172.
   PubMed Web of Science ®Google Scholar
• Kendall GC, Mokhonova EI, Moran M, et al. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy. Sci Transl Med. 2012;4:164ra160.
   PubMed Web of Science ®Google Scholar
• Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet. 2017;136:1193–1214.
   PubMed Web of Science ®Google Scholar
• Polymenidou M, Lagier-Tourenne C, Hutt KR, et al. Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res. 2012;1462:3–15.
   PubMed Web of Science ®Google Scholar
• Taylor JP, Brown RH, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197–206.
   PubMed Web of Science ®Google Scholar
• Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study. Lancet Neurol. 2012;11:323–330.
   PubMed Web of Science ®Google Scholar
• Barker HV, Niblock M, Lee Y-B, et al. RNA misprocessing in C9orf72-linked neurodegeneration. Front Cell Neurosci. 2017;11:195.
   PubMed Web of Science ®Google Scholar
• Mori K, Weng SM, Arzberger T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335–1338.
   PubMed Web of Science ®Google Scholar
• Lee YB, Chen HJ, Peres JN, et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA Foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep. 2013;5:1178–1186.
   PubMed Web of Science ®Google Scholar
• Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602–611.
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–133.
   PubMed Web of Science ®Google Scholar
• Tollervey JR, Curk T, Rogelj B, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14:452–458.
   PubMed Web of Science ®Google Scholar
• Xiao S, Sanelli T, Dib S, et al. RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS. Mol Cell Neurosci. 2011;47:167–180.
   PubMed Web of Science ®Google Scholar
• Tollervey JR, Curk T, Rogelj B, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14:452–458.
   PubMed Web of Science ®Google Scholar
• Tank EM, Figueroa-Romero C, Hinder LM, et al. Abnormal RNA stability in amyotrophic lateral sclerosis. Nat Commun. 2018;9:2845.
   PubMed Web of Science ®Google Scholar
• Tada M, Doi H, Koyano S, et al. Matrin 3 is a component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am J Pathol. 2018;188:507–514.
   PubMed Web of Science ®Google Scholar
• Farrawell NE, Lambert-Smith IA, Warraich ST, et al. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci Rep. 2015;5:13416.
   PubMed Web of Science ®Google Scholar
• Johnson JO, Pioro EP, Boehringer A, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17:664–666.
   PubMed Web of Science ®Google Scholar
• Uemura Y, Oshima T, Yamamoto M, et al. Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cells. 2017;22:785–798.
   PubMed Web of Science ®Google Scholar
• Banerjee A, Vest KE, Pavlath GK, et al. Nuclear poly(A) binding protein 1 (PABPN1) and matrin3 interact in muscle cells and regulate RNA processing. Nucleic Acids Res. 2017;45:10706–10725.
   PubMed Web of Science ®Google Scholar
• Zhang ZC, Chook YM. Structural and energetic basis of ALS-causing mutations in the atypical proline–tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS). Proc Natl Acad Sci U S A. 2012;109:12017–12021.
   PubMed Web of Science ®Google Scholar
• Deng HX, Zhai H, Bigio EH, et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann Neurol. 2010;67:739–748.
   PubMed Web of Science ®Google Scholar
• Mailman MD, Heinz JW, Papp AC, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med. 2002;4:20–26.
   PubMed Web of Science ®Google Scholar
• Hua Y, Sahashi K, Hung G, et al. Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. Genes Dev. 2010;24:1634–1644.
   PubMed Web of Science ®Google Scholar
• Mendell JR, Al-Zaidy S, Shell R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713–1722.
   PubMed Web of Science ®Google Scholar
• Passini MA, Bu J, Richards AM, et al. Antisense oligonucleotides ameliorate symptoms of severe spinal muscular atrophy. Sci Transl Med. 2011;3:72ra18.
   PubMed Web of Science ®Google Scholar
• Azzouz M, Le T, Ralph G. Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J Clin Invest. 2004;114:1726–1731.
   PubMed Web of Science ®Google Scholar
• Naryshkin NA, Weetall M, Dakka A, et al. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science. 2014;345:688–693.
   PubMed Web of Science ®Google Scholar